Biliary Tract Cancers: Molecular Heterogeneity and New Treatment Options

Biliary Tract Cancers: Molecular Heterogeneity and New Treatment Options

Most patients with biliary tract cancer (BTC) are diagnosed with advanced disease, relapse rates are high in those undergoing surgery and prognosis remains poor, while the incidence is increasing. Treatment options are limited, and chemotherapy is still the standard of care in both adjuvant and adva...

Full description

Bibliographic Details
Main Authors: Nicola Personeni, Ana Lleo, Tiziana Pressiani, Francesca Colapietro, Mark Robert Openshaw, Chara Stavraka, Athanasios Pouptsis, David James Pinato, Lorenza Rimassa
Format: Article
Language:English
Published: MDPI AG 2020-11-01
Series:Cancers
Subjects:
biliary tract cancer
cholangiocarcinoma
molecular characterization
tumor heterogeneity
FGFR
IDH
Online Access:https://www.mdpi.com/2072-6694/12/11/3370

Internet

https://www.mdpi.com/2072-6694/12/11/3370

Similar Items